IP Licensing, Commercialization, and Technology Transfer

Representative experience

Advising large Japanese pharma company on its bid for a licence for a cancer drug from a UK biotechnology company involving a review of the patent situation in 19 jurisdictions.

Advising a public sector organization on the establishment of a US$800m SAP-based business transformation framework agreement.

Advising a manufacturer of construction equipment on IP licenses and technical services agreements in joint ventures with Chinese and Japanese entities.

Advising Genzyme on its strategic agreement with Bayer regarding Genzyme's hematologic oncology portfolio, including worldwide rights for Alemtuzumab (earn-out arrangement).

Webinar

APAC Life Sciences and Health Care Webinar Series - Spotlight on Greater China - Session 3

28 September 2022 | 8:30 a.m. - 10:00 a.m. BST | 9:30 a.m. - 11:00 a.m. CET | 3:30 p.m. - 5:00 p.m. CST | 4:30 p.m. - 6:00 p.m. JST

Webinar No. 3: Out-licensing to Chinese counterparties, including related necessary IP protections

Webinar

Select IP with Hogan Lovells | Webinar no. 8: Patent Litigation: Discovery & evidence-gathering (Part II)

17 November 2021 | 3:00 PM - 4:30 PM (JST)

Our eighth session was on discovery (disclosure) and evidence-gathering in patent litigation with Dr Frederick Ch'en, Natalia Gulyaeva, Stephen Bennett, Rebecca Horton, Zhen (Katie) Feng...

Webinar

Select IP with Hogan Lovells | Webinar no. 7: Patent Litigation: Discovery & evidence-gathering (Part I)

14 October 2021 | 3:00 PM - 4:30 PM (JST)

Our seventh session was on discovery (disclosure) and evidence-gathering in patent litigation with Dr Frederick Ch'en, Giovanni Ghirardi, Inmaculada Lorenzo, Dr Martin Faehndrich, Ruud van...

Webinar

Select IP with Hogan Lovells | Webinar no. 6: Cross-over topics: Brexit

15 September 2021 | 3:00 PM - 4:30 PM (JST)

Our sixth session was on the practical implications of Brexit on IP – exploitation, enforcement and exhaustion with Dr Frederick Ch'en, Stephen Bennett, Katie McConnell and Sahira...

Hogan Lovells Events

WTO IP rights: The future of products combating COVID-19

Tuesday, June 15, 2021; 10:00 a.m. - 11:15 a.m. EDT; 2:00 p.m. - 3:15 p.m. GMT; 4:00 p.m. - 5:15 p.m. CEST

The Biden Administration recently announced that it would support the request for a World Trade Organization (WTO) waiver of intellectual property (IP) rights under the WTO Agreement on...

Brochures

Hogan Lovells automotive and mobility thought leadership paper

24 September 2020

Our latest thought leadership piece looks at immediate measures, introduces ACES 2.0, examines what living mobility has to do with the future of mobility and also focuses on horizon...

View more publications

IP Licensing, Commercialization, and Technology Transfer

Representative experience

APAC Life Sciences and Health Care Webinar Series - Spotlight on Greater China - Session 3

Select IP with Hogan Lovells | Webinar no. 8: Patent Litigation: Discovery & evidence-gathering (Part II)

Select IP with Hogan Lovells | Webinar no. 7: Patent Litigation: Discovery & evidence-gathering (Part I)

Select IP with Hogan Lovells | Webinar no. 6: Cross-over topics: Brexit

WTO IP rights: The future of products combating COVID-19

Hogan Lovells automotive and mobility thought leadership paper

Key contacts

Related practices